Equipotent doses of pegylated epoetin β (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice

1. Escudero Vilaplana, V.
2. Plata Paniagua, S.
3. Ais Larisgoitia, A.
4. Rodríguez González, C.
5. Bellón Cano, J.Ma.
6. Sanjurjo Sáez, Ma.